Chlorzoxazone
Back to searchMolecule Structure
Scientific Name
Chlorzoxazone
Description of the Drug
Chlorzoxazone is a drug with muscle relaxant properties that is used as an adjunct to physical therapy and analgesics to treat stiffness and pain caused by a variety of musculoskeletal conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00356
http://www.drugbank.ca/drugs/DB00356
Brand Name(s)
Chlorzoxazone, Paraflex, Parafon, Parafon Forte, Parafon-Forte, Parafon forte dsc, Strifon, Strifon forte dsc
Company Owner(s)
Watson Laboratories Inc, Par Pharmaceutical Inc, Mayne Pharma Llc, Rising Pharma Holdings Inc, Sun Pharmaceutical Industries Inc, I3 Pharmaceuticals Llc, Aurobindo Pharma Ltd, Teva Pharmaceuticals Usa Inc, Ortho Mcneil Pharmaceutical Inc, Janssen Research And Development Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Intermediate conductance calcium-activated potassium channel protein 4 | SINGLE PROTEIN | OPENER | CHEMBL4305 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35177 | |
| PharmGKB | PA448971 | |
| Human Metabolome Database | HMDB0014500 | |
| WDI | CHLORZOXA | |
| DrugBank | DB00356 | |
| PubChem: Thomson Pharma | 16935856 | |
| PubChem | 2733 | |
| Mcule | MCULE-3638156868 | |
| NMRShiftDB | 20146194 | |
| LINCS | LSM-6011 | |
| Nikkaji | J3.950K | |
| PDBe | CLW | |
| BindingDB | 50290811 | |
| EPA CompTox Dashboard | DTXSID9022813 | |
| DrugCentral | 626 | |
| Brenda | 21821 | |
| ChemicalBook | CB0392987 | |
| Guide to Pharmacology | 2322 | |
| GSRS | 5ff21aa0-fefa-44f1-a4e8-c75ed0ab1fa8 | |
| rxnorm | CHLORZOXAZONE | PARAFON FORTE DSC |
| KEGG Ligand | C07931 | |
| ChEBI | 3655 | |
| NIH Clinical Collection | SAM002554888 | |
| ZINC | ZINC000084843283 |
